Search results
Researchers infected 36 people with COVID to understand why some are less likely to get the virus
Euronews via Yahoo News· 11 hours agoResearchers infected 36 people with the virus that causes COVID-19 to understand why some people...
Cellular Fountain of Youth: New T-Cell Discovery Rewrites the Rules of Aging
SciTechDaily· 3 days agoMost cell types undergo functional decline after extensive proliferation and replication over the...
A new 'one-two punch' method for improving checkpoint inhibitor therapy for cancers, including...
Medical Xpress· 1 day agoA Scripps Research team has now found that ruxolitinib, an approved immunosuppressive drug,...
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 3 hours agoBlenrep is expected to introduce new competition for J&J and Legend Biotech’s BCMA CAR-T Carvykti...
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
The Conversation· 2 days agoIn the last few decades, scientists have finally learned to harness the immune system to successfully treat cancer. Car-T therapy, short for “chimeric antigen receptor < ...
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
InvestorPlace· 4 days agoThe recent news includes favorable results from the company’s Phase 1/2 clinical trial of MB-106. This is a CD20-targeted, autologous CAR T-cell
New research points to 'stem-like' T cells as culp | Newswise
Newswise· 4 days agoLA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have shed light on how an unusual population of T cells may drive harmful inflammation in people with ulcerative colitis, an ...
Fred Hutchinson Cancer Center develops biomaterial-based scaffold for cancer
Medical Device Network via Yahoo Finance· 2 days agoThese engineered cells could also locate and eliminate cancer cells in other body parts. Comparative...
Postdoc to investigate molecular mechanisms in the field immune-rejuvenation for drug discovery -...
Nature· 4 days agoIn the compelling and unstoppable research in favor of cellular rejuvenation, Sentcell LTD is looking for PhD or Postdoc Researchers to investigate molecular mechanisms and innovative therapies ...
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
MedPage Today· 3 days agoHigh-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line